HIV
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. diagnosised with HIV infection. 2. Taking Highly Active Antiretroviral Therapy (HAART) for more than 6 months and undetectable HIV-RNA levels (<50 copies/ml) within the past 3 months. 3. over 18 years or above, with no gender restrictions. 4. Capable of understanding and providing written informed consent. 5. Demonstrates good compliance and is able to cooperate in completing all required examinations and follow-ups during the study period.
Exclusion criteria
Exclusion criteria: 1. History of organ transplantation, active malignant tumors, or other severe complications. 2. Received immunosuppressive therapy or chemotherapy within the last 3 months prior to baseline visit. 3. Anticipated receipt of these medications or continuous steroid therapy during the study period. 4. Pregnant or lactating women. 5. Patients with unstable mental states or cognitive impairments. 6. Any other conditions deemed unsuitable for study participation by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Complete Blood Count ;C-Reactive Protein; | — |
Secondary
| Measure | Time frame |
|---|---|
| T-Lymphocyte Count;HIV-RNA Viral Load; | — |
Countries
China
Contacts
The Public Health Clinical Center of Chengdu